These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [The measurement of interleukin 1 (IL 1) and interleukin 2 (IL 2) employing the MTT assay]. Mukaida N, Kawai T, Kasahara T, Shioiri-Nakano K, Takahashi H. Rinsho Byori; 1985 Nov; 33(11):1279-83. PubMed ID: 3879297 [No Abstract] [Full Text] [Related]
11. Comparison of [3H]thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity. Gieni RS, Li Y, HayGlass KT. J Immunol Methods; 1995 Nov 16; 187(1):85-93. PubMed ID: 7490461 [Abstract] [Full Text] [Related]
13. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M. Cancer Res; 1997 Oct 15; 57(20):4557-63. PubMed ID: 9377569 [Abstract] [Full Text] [Related]
14. Optimization and comparison of the MTT assay and the 3H-TdR assay for the detection of IL-2 in helper T cell precursor assays. Russell CA, Vindelov LL. J Immunol Methods; 1998 Aug 01; 217(1-2):165-75. PubMed ID: 9776586 [Abstract] [Full Text] [Related]
15. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence. Yoshimura K, Hazama S, Iizuka N, Yoshino S, Yamamoto K, Muraguchi M, Ohmoto Y, Noma T, Oka M. Cancer Gene Ther; 2001 Jan 01; 8(1):9-16. PubMed ID: 11219497 [Abstract] [Full Text] [Related]
18. Evaluation of X-radiation and UV-B radiation for elimination of 3H-thymidine incorporation into responder cells in the IL-2 producing helper T lymphocyte precursor assay. Russell CA, Wulf HC, Sørensen PB, Vindeløv LL. J Immunol Methods; 1998 Nov 01; 220(1-2):161-8. PubMed ID: 9839937 [Abstract] [Full Text] [Related]
19. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient. Doucet C, Meazza R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boye D, Ferrini S, Alileche A, Taoufik Y, Jasmin C, Azzarone B, Indiveri F. Melanoma Res; 1997 Aug 01; 7 Suppl 2():S7-17. PubMed ID: 9578412 [Abstract] [Full Text] [Related]
20. Measurement of human and murine interleukin 2 and interleukin 4. Davis LS, Lipsky PE, Bottomly K. Curr Protoc Immunol; 2001 May 01; Chapter 6():Unit 6.3. PubMed ID: 18432816 [Abstract] [Full Text] [Related] Page: [Next] [New Search]